Cargando…

Ritonavir Blocks Hepatitis E Virus Internalization and Clears Hepatitis E Virus In Vitro with Ribavirin

Hepatitis E virus (HEV) is increasingly recognized as the leading cause of acute hepatitis. Although HEV infections are mostly self-limiting, a chronic course can develop especially in those with immunocompromised state. Ribavirin is currently used to treat such patients. According to various report...

Descripción completa

Detalles Bibliográficos
Autores principales:	Primadharsini, Putu Prathiwi, Nagashima, Shigeo, Takahashi, Masaharu, Murata, Kazumoto, Okamoto, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697947/ https://www.ncbi.nlm.nih.gov/pubmed/36366538 http://dx.doi.org/10.3390/v14112440

Ejemplares similares

Genetic Variability and Evolution of Hepatitis E Virus
por: Primadharsini, Putu Prathiwi, et al.
Publicado: (2019)

Development and Characterization of Efficient Cell Culture Systems for Genotype 1 Hepatitis E Virus and Its Infectious cDNA Clone
por: Primadharsini, Putu Prathiwi, et al.
Publicado: (2023)

Mechanism of Cross-Species Transmission, Adaptive Evolution and Pathogenesis of Hepatitis E Virus
por: Primadharsini, Putu Prathiwi, et al.
Publicado: (2021)

Infection Dynamics and Genomic Mutations of Hepatitis E Virus in Naturally Infected Pigs on a Farrow-to-Finish Farm in Japan: A Survey from 2012 to 2021
por: Takahashi, Masaharu, et al.
Publicado: (2023)

Three Distinct Reporter Systems of Hepatitis E Virus and Their Utility as Drug Screening Platforms
por: Primadharsini, Putu Prathiwi, et al.
Publicado: (2023)

Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection
por: Gallacher, Jennifer, et al.
Publicado: (2023)

Culture systems for hepatitis E virus
por: Okamoto, Hiroaki
Publicado: (2012)

In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome
por: Todt, Daniel, et al.
Publicado: (2016)

Ribavirin for Chronic Hepatitis E Virus Infection in Ibrutinib-Exposed Patients
por: Protin, Caroline, et al.
Publicado: (2019)

A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis E in Liver Transplant Recipients in Japan
por: Inagaki, Yuki, et al.
Publicado: (2015)

The Capsid (ORF2) Protein of Hepatitis E Virus in Feces Is C-Terminally Truncated
por: Nishiyama, Takashi, et al.
Publicado: (2021)

Hepatitis B virus reactivation after successful treatment of hepatitis C virus with sofosbuvir and ribavirin: A case report and literature review
por: Miyasaka, Akio, et al.
Publicado: (2020)

Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin
por: Lhomme, Sebastien, et al.
Publicado: (2019)

Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection
por: Mulder, Midas B., et al.
Publicado: (2020)

Randomized trial of interferon‐ and ribavirin‐free ombitasvir/paritaprevir/ritonavir in treatment‐experienced hepatitis C virus–infected patients
por: Chayama, Kazuaki, et al.
Publicado: (2015)

A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan
por: Owada, Yohei, et al.
Publicado: (2020)

Ombitasvir/paritaprevir/ritonavir + dasabuvir +/- ribavirin in real world hepatitis C patients
por: Loo, Nicole, et al.
Publicado: (2019)

Chronic Infection with Hepatitis C Virus Subtype 1g in a Japanese Patient Successfully Treated with Glecaprevir/Pibrentasvir
por: Hatanaka, Takeshi, et al.
Publicado: (2021)

Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin
por: Qu, Changbo, et al.
Publicado: (2017)

Ribavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2019)

A 79-year-old Woman with Acute Hepatitis B Caused by the Infection of Subgenotype D1 Hepatitis B Virus in Japan: A Case Study
por: Hashimoto, Kosei, et al.
Publicado: (2018)

Selection of hepatitis C virus resistant to ribavirin
por: Feigelstock, Dino A, et al.
Publicado: (2011)

An Autopsy Case of Primary Biliary Cholangitis with Histological Submassive Hepatic Necrosis Caused by Acute Hepatitis E Virus Infection
por: Koyama, Mizuki, et al.
Publicado: (2021)

Mutagenic Effects of Ribavirin on Hepatitis E Virus—Viral Extinction versus Selection of Fitness-Enhancing Mutations
por: Todt, Daniel, et al.
Publicado: (2016)

Virulent Strain of Hepatitis E Virus Genotype 3, Japan
por: Takahashi, Kazuaki, et al.
Publicado: (2009)

Acute Liver Failure Caused by the Transmission of Hepatitis B Virus from the Spouse after 38 Years of Marriage
por: Sato, Naoto, et al.
Publicado: (2019)

Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study
por: Franz, Anika, et al.
Publicado: (2023)

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection
por: Kagawa, Tatehiro, et al.
Publicado: (2010)

Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature
por: Sato, Ken, et al.
Publicado: (2019)

Ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin for treatment of chronic hepatitis C 1 genotype in the Republic of Belarus
por: Danilau, Dzmitry, et al.
Publicado: (2017)

Co-infectivity of hepatitis B virus and hepatitis E virus
por: Singh, Akanksha, et al.
Publicado: (2012)

High antiviral activity of NS5A inhibitor ABT‐530 with paritaprevir/ritonavir and ribavirin against hepatitis C virus genotype 3 infection
por: Poordad, Fred, et al.
Publicado: (2016)

Ombitasvir, paritaprevir, and ritonavir with peginterferon-α2a plus ribavirin in treatment-experienced patients with chronic hepatitis C virus genotype 1 infection
por: Bernstein, David, et al.
Publicado: (2019)

Change in the hepatic profile of hepatitis C virus genotype 4–infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE‐II study
por: Waked, Imam, et al.
Publicado: (2018)

Hepatitis E Virus Replication
por: LeDesma, Robert, et al.
Publicado: (2019)

Hepatitis E Virus Entry
por: Yin, Xin, et al.
Publicado: (2019)

Hepatitis E Virus Immunopathogenesis
por: Yadav, Kush Kumar, et al.
Publicado: (2021)

Updates on hepatitis E virus
por: Liang, Zhaochao, et al.
Publicado: (2022)

Advances in Hepatitis E Virus
por: Fierro, Nora A.
Publicado: (2023)

Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice
por: van de Garde, Martijn D. B., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bm52ghljc4suc2r0uda8fvo84t